Final results of the PräVAC trial: prevention of wound complications following inguinal lymph node dissection in patients with penile cancer using epidermal vacuum-assisted wound closure - Scorecard - MDSpire
Advertisement
Final results of the PräVAC trial: prevention of wound complications following inguinal lymph node dissection in patients with penile cancer using epidermal vacuum-assisted wound closure
Clinical Scorecard: Outcomes of the PräVAC Study: Reducing Wound Complications After Inguinal Lymph Node Dissection in Penile Cancer Patients Through Epidermal Vacuum-Assisted Closure
At a Glance
Category
Detail
Condition
Penile cancer with inguinal lymph node metastasis risk
Key Mechanisms
Epidermal vacuum therapy applies negative pressure to closed wounds, stabilizing and promoting healing by compressing lymphatic vessels and removing wound fluid
Target Population
Patients undergoing inguinal lymphadenectomy for penile cancer
Care Setting
Surgical inpatient setting in specialized urology centers
Key Highlights
Inguinal lymphadenectomy is recommended for staging and treatment in penile cancer patients with intermediate/high risk or clinically suspicious lymph nodes but is associated with high wound morbidity (25–70%)
Epidermal vacuum wound dressing (VAC) significantly reduces lymphocele formation, persistent lymphorrhea, and lymphedema compared to conventional wound care
The PräVAC study is a prospective, randomized, multicenter trial confirming the benefits of epidermal vacuum therapy in reducing wound complications after inguinal lymph node dissection
Guideline-Based Recommendations
Diagnosis
Perform surgical lymph node staging (dynamic sentinel node biopsy or modified inguinal lymphadenectomy) in penile cancer patients with ≥ pT1 G2 tumors
Radical inguinal lymphadenectomy advised for clinically suspicious inguinal lymph nodes
Management
Use epidermal vacuum wound dressing (e.g., PREVENA™ Incision Dressing) on closed inguinal wounds post-lymphadenectomy to reduce wound complications
Prefer ligation over diathermic coagulation during surgery to reduce morbidity
Apply subcutaneous suction drain and pressure dressing in conventional care; epidermal vacuum therapy includes suction drain plus vacuum dressing
Monitoring & Follow-up
Remove epidermal vacuum dressing after 7–8 days; remove pressure dressing after 24 hours in conventional care
Remove suction drainage when daily fluid volume is < 25 ml but not before postoperative day 3
Perform bilateral inguinal sonography before hospital discharge to assess wound status
Document wound complications during hospital stay and assess patient pain and satisfaction using visual analogue scales
Risks
High morbidity associated with inguinal lymphadenectomy includes prolonged lymph secretion, lymphocele formation, wound dehiscence, and lymphedema
Avoidance of inguinal lymphadenectomy due to morbidity risk leads to higher mortality in penile cancer patients
Patient & Prescribing Data
Penile cancer patients undergoing bilateral inguinal lymphadenectomy or dynamic sentinel node biopsy
Epidermal vacuum therapy applied on one groin side and conventional care on the other within the same patient allows direct comparison, showing reduced wound complications and reinterventions with vacuum therapy
Clinical Best Practices
Adhere to EAU guidelines for inguinal lymphadenectomy indications in penile cancer
Use epidermal vacuum wound dressing postoperatively to minimize lymphatic complications
Apply randomized side allocation for wound dressing in clinical trials to control patient-specific confounders
Monitor wound fluid output closely to guide drain removal timing
Assess patient-reported pain and satisfaction to evaluate wound care effectiveness